Mr Richard Steyn

UK Lung Cancer Coalition / University Hospitals Birmingham NHS Foundation Trust

Mr Richard Steyn, is a Consultant Thoracic Surgeon, Deputy Medical Director, University Hospitals Birmingham NHS Foundation Trust and Honorary Associate Professor, University of Warwick and the Chair of the UK Lung Cancer Coalition – the largest UK multi-interest group in lung cancer comprising leading lung cancer experts, senior NHS professionals, all key cancer charities, British Lung Foundation and healthcare companies. He is a member of the Thoracic Surgery sub-committee of the Society for Cardiothoracic Surgery of Great Britain and Ireland.

dont miss

Doubling Five-Year UK Lung Cancer Survival to 25% by 2025

The UK Lung Cancer Coalition (UKLCC) was set up in 2005 with the founding ambition of tackling poor survival outcomes and, specifically to double 5-year survival by 2015, which has now effectively been achieved (in England). The UKLCC is now calling for governments, commissioners and the health care community to re-double efforts and work together to raise 5-year rates to 25% by 2025 across the UK.

Mr Richard Steyn will be speaking in the following theatre:

Theatre 12 - Tuesday 14.00 - 14.30: Doubling Five-Year UK Lung Cancer Survival to 25% by 2025

EVEN MORE SEMINARS

  • Jamie Rae: Speaking at the Oncology Convention

    Jamie Rae
    Throat Cancer Foundation

    The Throat Cancer Foundation; how we changed a government’s mind

  • Prof. András SZÁSZ: Speaking at the Oncology Convention

    Prof. András SZÁSZ
    St. Istvan University

    Modulated electrohyperthermia (mEHT) for advanced malignant tumors

  • Professor Hisham Mehanna: Speaking at the Oncology Convention

    Professor Hisham Mehanna
    InHANSE, Institute of Cancer and Genomic Sciences, University of Birmingham

    Clinical trials that change patient care and the lessons learnt

  • Ms Claire Barnard: Speaking at the Oncology Convention

    Ms Claire Barnard
    GenesisCare

    Surface-Guided Radiotherapy and Optimal Breast Cancer Treatment

  • Stefan Schuster: Speaking at the Oncology Convention

    Stefan Schuster
    Datar Cancer Genetics Limited

    Clinical Utility of Liquid Biopsy in Brain Tumors